UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022770
Receipt number R000026242
Scientific Title Characteristics of Hyperautofluorescent Choroidal Vessels Using Fundus Camera Type Short-wavelength Autofluorescence
Date of disclosure of the study information 2016/07/14
Last modified on 2019/03/05 19:41:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Characteristics of Hyperautofluorescent Choroidal Vessels Using Fundus Camera Type Short-wavelength Autofluorescence

Acronym

Hyperautofluorescent choroidal vessels

Scientific Title

Characteristics of Hyperautofluorescent Choroidal Vessels Using Fundus Camera Type Short-wavelength Autofluorescence

Scientific Title:Acronym

Hyperautofluorescent choroidal vessels

Region

Japan


Condition

Condition

Normal eyes

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify characteristics of hyperautofluorescent choroidal vessels using fundus autofluorescence with an excitation wavelength over 520nm.

Basic objectives2

Others

Basic objectives -Others

Hyperautofluorescent choroidal vessels in both nasal and temporal portions of the same eye (group 1) and only in the nasal portion of the same eye (group 2) were studied.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Choroidal and retinal thicknesses (at the fovea, nasal and temporal portions 3,000 micrometer from the fovea) were compared between the two groups.

Key secondary outcomes

Axial length and refractive error were compared between groups.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Eyes with hyperautofluorescent choroidal vessels in either the nasal only or both nasal and temporal portions. Images were obtained with a fundus camera type and axial length measurements were obtained retrospectively from medical records.

Key exclusion criteria

Eyes with age-related macular degeneration, epiretinal membrane, macular hole and other ocular fundus disorders were excluded.

Target sample size

26


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ari Shinojima

Organization

Nihon University School of Medicine

Division name

Division of Ophthalmology, Department of Visual Sciences

Zip code


Address

1-6, Surugadai, Kanda, Chiyoda-ku, Tokyo

TEL

+81332931711

Email

shinojima.ari@nihon-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ari Shinojima

Organization

Nihon University School of Medicine

Division name

Division of Ophthalmology, Department of Visual Sciences

Zip code


Address

1-6, Surugadai, Kanda, Chiyoda-ku, Tokyo

TEL

+81332931711

Homepage URL


Email

shinojima.ari@nihon-u.ac.jp


Sponsor or person

Institute

Nihon University Hospital

Institute

Department

Personal name



Funding Source

Organization

Nihon University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 07 Month 14 Day


Related information

URL releasing protocol

https://www.ncbi.nlm.nih.gov/pubmed/27614990

Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/27614990

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 18 Day

Date of IRB


Anticipated trial start date

2016 Year 05 Month 18 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In group 1 (n=19), the average foveal, nasal, and temporal choroidal thicknesses were 69, 57, and 88 micrometer, refractive error was -10D, axial length 28mm, and the average foveal, nasal, and temporal retinal thicknesses were 170, 222, and 209 micrometer. In group 2 (n=17), the respective values were 175, 80, 174 micrometer, -2D, 24mm, 213, 278, and 253 micrometer. There were significant between group differences for all items (p<0.05) except age.


Management information

Registered date

2016 Year 06 Month 16 Day

Last modified on

2019 Year 03 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026242


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name